A summary of the reported use of JAK inhibitors to treat cutaneous and systemic sarcoidosis.

Published: 11 August 2021| Version 1 | DOI: 10.17632/jknxdjmm7b.1
Contributors:
Ronan Talty,
,

Description

A summary of the reported use of JAK inhibitors to treat cutaneous and systemic sarcoidosis. CR – complete response; NCR – near complete response; PR – partial response.

Files